Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000929638-26-004231·TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock · CUSIP: 34962G208
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Shares: 0 · Class: 0%
- TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED
Shares: 0 · Class: 0%
- Tybourne Kesari Ltd
Shares: 0 · Class: 0%
- Krishnan Viswanathan
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-26-004231
- Form type
- SCHEDULE 13G/A
- Filer
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD
- CIK
- CIK 1553936
- Filed
- Nov 04, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership